Zhang L, Mao W, Guo X, et al. Ginkgo biloba extract for patients with early diabetic nephropathy: a systematic review[J]. Evid Based Complement Alternat Med, 2013, doi:689142.
Taliyan R, Sharma P L. Protective effect and potential mechanism of Ginkgo biloba extract EGb 761 on STZ-induced neuropathic pain in rats[J]. Phytother Res, 2012, 26(12):1823.
[7]
Kim J, Yokoyama K, Araki S. The effects of Ginkgo Biloba extract (GBe) on axonal transport, microvasculature and morphology of sciatic nerve in streptozotocin-induced diabetic rats[J]. Environ Health Prev Med, 2000, 5: 53.
Wu Z M, Yin X X, Ji L, et al. Ginkgo biloba extract prevents against apoptosis induced by high glucose in human lens epithelial cells[J]. Acta Pharmacol Sin, 2008,29(9):1042.
[11]
Chan P C, Xia Q, Fu P P. Ginkgo biloba leave extract: biological, medicinal, and toxicological effects[J]. J Environ Sci Health C, 2007, 25:211.
Ren M, Yang S, Li J. Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress[J]. Endocrine, 2013, 43:360.
[16]
Cheng D, Liang B, Li Y, et al. Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats[J]. Biomed Res Int, 2013, doi:10.1155/2013/162724.
[17]
Lim S, Yoon J W, Kang S M, et al. EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes[J]. PLoS ONE, 2011, 6(6): e20301.
Qian L, Yin X, Wang J, et al. Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats[J]. Acta Pharmacol Sin, 2007, 28 (6): 818.
[22]
Kudolo G B. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus[J]. J Clin Pharmacol, 2001, 41(6):600.
[23]
Kudolo G B. The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals[J]. J Clin Pharmacol, 2000, 40(6):647.
[24]
Rudge M V, Damasceno D C, Volpato G T, et al. Effect of Ginkgo biloba on the reproductive outcome and oxidative stress biomarkers of streptozotocin induced diabetic rats[J]. Braz J Med Biol Res, 2007, 40: 1095.
[25]
Vasseur M, Jean T, DeFeudis F V, et al. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes[J]. Gen Pharmacol, 1994, 25:31.
[26]
Kudolo G B, Delaney D, Blodgett J. Short-term oral ingestion of Ginkgo biloba extract (EGb761) reduces malondiadehyde levels in washed platelets of type 2 diabetes subjects[J]. Diabetes Res Clin Pract, 2005, 68(1):29.
Choi S E, Shin H C, Kim H E, et al. Involvement of Ca2+, CaMK II and PKA in EGb 761-induced insulin secretion in INS-1 cells[J]. J Ethnopharmacol, 2006, 110(1): 49.
Sugiyama T, Kubota Y, Shinozuka K, et al. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats[J]. Life Sci, 2004,75(9): 1113.
[40]
Schneider R, Welt K, Aust W, et al. Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: II. Interstitium and microvasculature[J]. Histol Histopathol, 2008, 23(7):807.
[41]
Welt K, Fitzl G, Schepper A. Experimental hypoxia of STZ-diabetic rat myocardium and protective effects of Ginkgo biloba extract[J]. Exp Toxicol Pathol, 2001, 52(6):503.
[42]
Welt K, Weiss J, Koch S, et al. Protective effects of Ginkgo biloba extract EGb 761 on the myocardium of experimentally diabetic rats II. Ultrastructural and immunohistochemical investigation on microvessels and interstitium[J]. Exp Toxic Pathol, 1999, 51: 213.
Tsai H Y, Huang P H, Lin F Y, et al. Ginkgo biloba extract reduces high-glucose-induced endothelial reactive oxygen species generation and cell adhesion molecule expression by enhancing HO-1 expression via Akt/eNOS and p38 MAP kinase pathways[J]. Eur J Pharm Sci, 2013,48(4/5): 803.
[45]
Chen J S, Chen Y H, Huang P H, et al. Ginkgo biloba extract reduces high-glucose induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways[J]. Cardiovasc Diabetol, 2012,11:49.
Ji L, Yin X X, Wu Z M, et al. Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells[J]. Phytother Res, 2009, 23: 477.
Welt K, Weiss J, Martin R, et al. Ginkgo biloba extract protects rat kidney from diabetic and hypoxic damage[J]. Phytomedicine, 2007,14(2/3): 196.
[51]
Huang S Y, Jeng C, Kao S C, et al. Improved haemorrheological properties by Ginkgo biloba extract (Egb761) in type 2 diabetes mellitus complicated with retinopathy[J]. Clin Nutr, 2004, 23: 615.